切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2019, Vol. 13 ›› Issue (02) : 120 -123. doi: 10.3877/cma.j.issn.1674-0785.2019.02.008

所属专题: 文献

临床研究

Caprini和Pauda风险评估模型联合使用对筛选内科住院患者静脉血栓栓塞症的应用价值
刘亚群1, 韩东岳1, 程兆忠2,()   
  1. 1. 266000 青岛大学
    2. 266000 青岛大学附属医院呼吸内科
  • 收稿日期:2018-10-27 出版日期:2019-01-15
  • 通信作者: 程兆忠

Value of combination of Caprini and Padua risk assessment models for venous thromboembolism screening in patients in department of internal medicine

Yaqun Liu1, Dongyue Han1, Zhaozhong Cheng2,()   

  1. 1. Qingdao University, Qingdao 266000, China
    2. Department of Respiratory Medicine, Affiliated Hospital of Qingdao University, Qingdao 266000, China
  • Received:2018-10-27 Published:2019-01-15
  • Corresponding author: Zhaozhong Cheng
  • About author:
    Corresponding author: Cheng Zhaozhong, Email:
引用本文:

刘亚群, 韩东岳, 程兆忠. Caprini和Pauda风险评估模型联合使用对筛选内科住院患者静脉血栓栓塞症的应用价值[J]. 中华临床医师杂志(电子版), 2019, 13(02): 120-123.

Yaqun Liu, Dongyue Han, Zhaozhong Cheng. Value of combination of Caprini and Padua risk assessment models for venous thromboembolism screening in patients in department of internal medicine[J]. Chinese Journal of Clinicians(Electronic Edition), 2019, 13(02): 120-123.

目的

验证Caprini和Padua风险评估模型联合使用在内科住院患者中筛选静脉血栓栓塞症(VTE)的有效性。

方法

采用单中心回顾性研究,分析从2017年8~12月青岛大学附属医院内科住院患者资料,以Caprini和Padua风险评估模型对所有患者进行回顾性血栓风险评分,并通过Logistic二分类回归分析得到Caprini和Padua联合使用后的预测概率模型,分别绘制3种模型的受试者工作特征曲线(ROC),采用Delong法比较3种模型的曲线下面积,以Youden指数最大的分界点作为最佳诊断分界点。

结果

Caprini和Padua联合使用后的预测概率模型ROC曲线下面积高于Caprini模型和Padua模型(0.927±0.009 vs 0.739±0.020,0.927±0.009 vs 0.817±0.017),差异具有统计学意义(Z=10.659,Z=8.952,P均<0.001)。并且预测概率模型灵敏度及特异度均大于Caprini或Padua(83.7% vs 79.1% vs 72.1%;87.9% vs 66.7% vs 82.7%)。

结论

Caprini和Padua风险评估模型联合使用可提高筛选内科住院患者VTE的准确性。

Objective

To verify the efficacy of Caprini and Padua risk assessment models in screening of venous thromboembolism in patients in the department of internal medicine.

Methods

A single center retrospective study was performed in the inpatients at the Affiliated Hospital of Qingdao University from August 2017 to December. The Padua and Caprini risk scores were record retrospectively for each patient. Meanwhile, logistic bivariate regression analysis was performed to assess the predictive ability of combined Caprini and Padua risk assessment models for diagnosis of VTE. The operating characteristic curves (ROC) were plotted to calculate the area under the curve and pairwise comparisons were then performed. The cutoff point was chosen based on the Youden index.

Results

The area under the ROC curve of the combination model was significantly higher than that of Caprini or Padua model alone (0.927±0.009 vs 0.739±0.020, Z=10.659, P<0.001; 0.927±0.009 vs 0.817±0.017, Z=8.952, P<0.001).The sensitivity and specificity of the combination model were also higher than those of Caprini or Padua model alone (83.7% vs 79.1% vs 72.1%; 87.9% vs 66.7% vs 82.7%).

Conclusion

The combination of Caprini and Padua risk assessment models can improve the accuracy of screening for VTE in patients in the department of internal medicine.

表1 Caprini和Padua风险评估模型在内科住院患者中评价结果(例)
图1 Caprini、Padua和预测概率模型ROC曲线
表2 3种模型的敏感度、特异度及约登指数
1
Kroegel C, Reissig A. Principle mechanisms underlying venous thromboembolism: epidemiology, risk factors, pathophysiology and pathogenesis [J]. Respiration, 2003, 70(1): 7-30.
2
恽佶例, 李小鹰. 静脉血栓栓塞症的病理流行病学研究状况 [J]. 中华老年心脑血管病杂志, 2017, 19(3): 322-324.
3
Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) [J]. Chest, 2008, 133(6 Suppl): 381S-453S.
4
Alikhan R, Peters F, Wilmott R, et al. Fatal pulmonary embolism in hospitalised patients: a necropsy review [J]. J Clin Pathol, 2004, 57(12): 1254-1257.
5
Angchaisuksiri P. Venous thromboembolism in Asia--an unrecognised and under-treated problem? [J]. Thromb Haemost, 2011, 106(4): 585-590.
6
Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J]. Chest, 2012, 141(2 Suppl): e227S-e277S.
7
Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score [J]. J Thromb Haemost, 2010, 8(11): 2450-2457.
8
Kearon C, Akl EA, Ornelas J, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report [J]. Chest, 2016, 149(2): 315-352.
9
Bahl V, Hu HM, Henke PK, et al. A validation study of a retrospective venous thromboembolism risk scoring method [J]. Ann Surg, 2010, 251(2): 344-350.
10
Pannucci CJ, Bailey SH, Dreszer G, et al. Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients [J]. J Am Coll Surg, 2011, 212(1): 105-112.
11
Stroud W, Whitworth JM, Miklic M, et al. Validation of a venous thromboembolism risk assessment model in gynecologic oncology [J]. Gynecol Oncol, 2014, 134(1): 160-163.
12
Zakai NA, Wright J, Cushman M. Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score [J]. J Thromb Haemost, 2004, 2(12): 2156-2161.
13
Pop TR, Vesa SC, Trifa AP, et al. PAI-1 4G/5G and MTHFR C677T polymorphisms increased the accuracy of two prediction scores for the risk of acute lower extremity deep vein thrombosis [J]. Rom J Morphol Embryol, 2014, 55(1): 153-157.
14
Nendaz M, Spirk D, Kucher N, et al. Multicentre validation of the Geneva Risk Score for hospitalised medical patients at risk of venous thromboembolism. Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE) [J]. Thromb Haemost, 2014, 111(3): 531-538.
[1] 曾敬, 赵洪普, 杨展翔, 张静云, 郑兆宽, 吴宝杰. 全膝关节置换术后静脉血栓栓塞症危险因素的Meta分析[J]. 中华关节外科杂志(电子版), 2019, 13(01): 78-85.
[2] 孙莉莉, 李晓强, 张明, 朱健, 黄佃. 非编码RNAs调控内皮祖细胞对静脉血栓的影响[J]. 中华细胞与干细胞杂志(电子版), 2022, 12(03): 181-185.
[3] 陈慧娟, 张艳, 李立, 王红莉, 赵思萌, 李冰冰, 赵佳音, 孔祥燕. 预防骨科患者静脉血栓栓塞症的循证实践[J]. 中华肩肘外科电子杂志, 2022, 10(02): 162-168.
[4] 鲁春蕾, 刘昌华. 特发性膜性肾病并发静脉血栓栓塞症的研究进展[J]. 中华肾病研究电子杂志, 2020, 09(05): 220-223.
[5] 黄月明, 杨冬武, 李港, 韩光魁, 崔昌萌, 靳峰. 院前使用抗凝剂对颅脑损伤后预防VTE的影响[J]. 中华神经创伤外科电子杂志, 2018, 04(01): 46-49.
[6] 黄丽槐, 黄钢勇, 吴建国, 魏亦兵, 王思群, 夏军. 股骨颈骨折行髋关节置换术患者血沉、C反应蛋白和D-二聚体的变化及临床意义[J]. 中华老年骨科与康复电子杂志, 2019, 05(02): 62-67.
[7] 史亚东, 顾建平. 无症状肺栓塞的诊断与治疗进展[J]. 中华介入放射学电子杂志, 2023, 11(02): 155-158.
[8] 彭波, 卡德尔江·木沙, 刘娜, 于长辉, 喻天启, 范红友, 李智. 新疆克州静脉血栓栓塞症的危险因素及发病特征分析[J]. 中华介入放射学电子杂志, 2022, 10(03): 250-253.
[9] 陈文, 农昌铭, 冯毅, 郑贵雄, 梁彦, 岑兴强, 张均辕, 钟宏. D-二聚体对肺癌围手术期静脉血栓栓塞症的最佳诊断值研究[J]. 中华介入放射学电子杂志, 2019, 07(04): 283-286.
[10] 刘东婷, 冯莹. 临床评分量表对预警院内深静脉血栓形成防治体系的临床价值[J]. 中华临床实验室管理电子杂志, 2021, 09(01): 12-18.
[11] 刘铠宾, 杨异. 单中心787例胸外伤患者静脉血栓栓塞症危险因素分析与风险预测模型构建[J]. 中华胸部外科电子杂志, 2023, 10(02): 57-62.
[12] 孙益鑫, 崔松平, 李辉, 刘毅, 柯立晖. 基于倾向性评分匹配法探讨肺外科围手术期静脉血栓栓塞症预防性抗凝的有效性及安全性[J]. 中华胸部外科电子杂志, 2021, 08(01): 21-35.
[13] 田博, 宋春凤, 李辉, 傅毅立, 张文谦, 胡晓星, 陈其瑞, 游宾, 陈硕, 李彤, 胡滨, 侯生才. Caprini和Rogers风险评估模型联合使用可以提高胸外科术后患者筛选静脉血栓栓塞症的准确性[J]. 中华胸部外科电子杂志, 2017, 04(03): 186-189.
[14] 黎鑫, 艾克拜尔·艾力, 克力木·阿不都热依木. 腹腔镜食管裂孔疝修补术围手术期静脉血栓栓塞症的危险因素和防治策略[J]. 中华胃食管反流病电子杂志, 2023, 10(01): 42-45.
阅读次数
全文


摘要